Advanced breast cancer patients are 10% more likely to develop CVD, highlighting the importance of timely diagnosis and screening updates. The study analyzed 19,292 women aged 66+ with breast cancer, ...

Patients worldwide increasingly turn to stage 4 breast cancer treatment abroad, as modern German clinics offer the latest ...

Breast cancer is a type of cancer that starts growing in the breast tissue. Healthcare providers classify breast cancer into five stages, stage 0 to stage 4. The stage indicates how advanced the ...

The lidERA Breast Cancer study is a phase 3, randomized, open-label trial testing whether the adjuvant therapy giredestrant ...

If you have stage IV breast cancer, the cancer has spread to areas like your bones, lungs, or liver. This cancer can't be cured, but many women live for five to 10 years after receiving this diagnosis ...

Lauren, a 35-year-old wife and mother of three daughters, had just finished breastfeeding her youngest when she first noticed ...

Kisqali (ribociclib), an oral treatment currently used to treat advanced breast cancer, may also reduce the odds of tumors coming back in patients with earlier-stage disease, a new study suggests. The ...

Roche (OTCQX:RHHBY) unit Genentech announced on Tuesday that giredestrant, a selective estrogen receptor degrader (SERD), ...

Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update One ...

Topline data were announced from a phase 3 trial evaluating giredestrant for the adjuvant treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive Phase III results from the lidERA Breast Cancer study evaluating investigational giredestrant as an ...